MACROPHAGE INFLAMMATORY PROTEINS AS MARKERS OF SEVERE COVID-19
- Authors: GRISHAEVA A.A.1, PONEZHEVA Z.B.1, CHANYSHEV M.D.2, ALESHINA N.I.3, MYASNIKOVA M.A.3, KRASNOVA S.V.3
-
Affiliations:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- N.I. Pirogov Russian National Research Medical University
- Infectious Disease Clinical Hospital Two, Moscow Healthcare Department
- Issue: Vol 12, No 1 (2022)
- Pages: 35-38
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287865
- DOI: https://doi.org/10.18565/epidem.2022.12.1.35-8
- ID: 287865
Cite item
Abstract
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Antonina A. GRISHAEVA
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: antoninagrishaeva@yandex.ru
Junior Researcher, Clinical Department of Infectious Pathology Moscow, Russia
Zhanna B. PONEZHEVA
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: doktorim@mail.ru
MD, Leading Researcher, Head, Clinical Department of Infectious Pathology Moscow, Russia
Mikhail D. CHANYSHEV
N.I. Pirogov Russian National Research Medical University
Email: chanish@mail.ru
Cand. Biol. Sci., Researcher, Laboratory of Molecular Oncology Moscow, Russia
Nina I. ALESHINA
Infectious Disease Clinical Hospital Two, Moscow Healthcare Department
Email: aleshina@list.ru
Cand. Med. Sci., Clinical and Laboratory Diagnostician, Clinical and Diagnostic Laboratory Moscow, Russia
Maria A. MYASNIKOVA
Infectious Disease Clinical Hospital Two, Moscow Healthcare Department
Email: myasnykova@mail.ru
Head, Department of COVID-19 Control Moscow, Russia
Svetlana V. KRASNOVA
Infectious Disease Clinical Hospital Two, Moscow Healthcare Department
Email: krasnovasv@ikb2.ru
Cand. Med. Sci., Chief Physician Moscow, Russia
References
- Huang C. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet 2020; 15-21(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
- Yingxia L. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. Nat. Sci. Rev. 2020; 7(6): 1003-11. doi: 10.1093/nsr/nwaa037
- Burgos-Blasco B., Güemes-Villahoz N., Santiago J.L. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients. Exp. Eye. Res. 2020; 200: 108253. doi: 10.1016/j.exer.2020.108253
- Ying Chi, Yiyue Ge, Bin Wu, Wenshuai Zhang, Tao Wu, Tian Wen et al. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J. Infect. Dis. 2020; 222(5): 746-54. doi: 10.1093/infdis/jiaa363
- Ionescu M.-A. COVID-19 skin lesions are rarely positive at RT-PCR test: the macrophage activation with vascular impact and SARS-CoV-2-induced cytokine storm.Int. J. Dermatol. 2022; 61(1): 3-6. doi: 10.1111/ijd.15749. Epub 2021 Jul 2.
- Young B.E., BChir M.B., Sean W X Ong et al. Viral dynamics and immune correlates of COVID-19 disease severity. Clin. Infect.Dis. 2020 Aug 28 : ciaa1280. doi: 10.1093/cid/ciaa1280
- Jorgensen M.J., Holter J.C., Christensen E.E. et al. Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19. Sci. Rep. 2020; 10: 21697. doi: 10.1038/s41598-020-78710-7
Supplementary files
![](/img/style/loading.gif)